Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent

US Patent 10260097 · Granted Apr 16, 2019

Assignee

Inventors

View full patent text on Google Patents →